诱导多能干细胞
生物
重编程
突变
桥粒蛋白
移植
外周血单个核细胞
癌症研究
复合杂合度
心肌病
细胞生物学
胚胎干细胞
遗传学
心力衰竭
细胞
内科学
基因
医学
体外
作者
Shu‐Tao Xia,Xvdong Wang,Peng Yue,Yifei Li,Donghui Zhang
标识
DOI:10.1016/j.scr.2020.101977
摘要
The mutations of desmoplakin (DSP) lead to arrhythmia right ventricular cardiomyopathy (ARVC) which is a kind of progressive cardiomyopathy characterized by arrhythmia, heart failure and sudden cardiac death. The human induced pluripotent stem (iPS) cell line HUBUi001-A was generated from a patient carrying the compound DSP heterozygous mutations (c.104G > T p.G35V; c.5617C > T p.R1873C), which were inherited from his parents (HUBUi002-A, HUBUi003- A), who presented a normal phenotype. We have derived the iPSC cell lines through peripheral blood mononuclear (PBMCs) cell reprogramming technology. Pluripotency and differentiation capacity have been confirmed by RT-PCR, immunocytochemistry and teratoma experiment. These cell lines can help us understand the pathogenic mechanism and screening potential therapeutic options.
科研通智能强力驱动
Strongly Powered by AbleSci AI